Can we harness the placebo effect to improve care in lower urinary tract dysfunction? ICI-RS 2019

V. Khullar, M.S. Rahnama'i, N. Veit-Rubin, L. Cardozo, A.J. Wein

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish
Pages (from-to)S80-S87
Number of pages8
JournalNeurourology and Urodynamics
Volume39
DOIs
Publication statusPublished - 1 Jul 2020

Keywords

  • bladder pain syndrome
  • clinical trials
  • clinical-trials
  • double-blind
  • drug trials
  • duloxetine
  • ethics
  • lower urinary tract symptoms
  • orally disintegrating tablet
  • overactive bladder
  • placebo
  • randomized controlled-trials
  • stress urinary incontinence
  • stress-incontinence
  • women
  • OVERACTIVE BLADDER
  • DULOXETINE
  • ORALLY DISINTEGRATING TABLET
  • ETHICS
  • RANDOMIZED CONTROLLED-TRIALS
  • DRUG TRIALS
  • WOMEN
  • CLINICAL-TRIALS
  • DOUBLE-BLIND
  • STRESS-INCONTINENCE

Cite this